ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,747.48
      -1.75%
      US Tech 100
      19,596.80
      -1.43%
      Dow Jones
      42,418.95
      -1.79%
      Brent Oil
      70.355
      -1.46%
      Bitcoin
      82,470.23
      -4.20%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Inhibrx Biosciences Inc (INBX) Quote

      Inhibrx Biosciences Inc

      Inhibrx Biosciences Inc (INBX)

      NASDAQ
      13.30
      -0.28
      ( -2.06% )
      Updated: 11:18:31
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      13.30
      Bid
      13.20
      Ask
      13.31
      Volume
      23,430
      12.82 Day's Range 13.33
      10.80 52 Week Range 36.00
      Market Cap
      192.53M
      Previous Close
      13.58
      Open
      13.33
      Last Trade
      100
      @
      13.3
      Last Trade Time
      11:18:31
      Financial Volume
      $ 308,363
      VWAP
      13.161
      Average Volume (3m)
      85,027
      Shares Outstanding
      14,475,904
      Dividend Yield
      -
      PE Ratio
      -1.23
      Earnings Per Share (EPS)
      -10.71
      Revenue
      1.63M
      Net Profit
      -154.96M

      About Inhibrx Biosciences Inc

      We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence. We are a clinical-stage biotechnology company dedicated to helping people with life-threatening conditions through scientific innovation and excellence.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.inhibrx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Inhibrx Biosciences Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker INBX. The last closing price for Inhibrx Biosciences was $13.58. Over the last year, Inhibrx Biosciences shares have traded in a share price range of $ 10.80 to $ 36.00.

      Inhibrx Biosciences currently has 14,475,904 shares outstanding. The market capitalization of Inhibrx Biosciences is $196.58 million. Inhibrx Biosciences has a price to earnings ratio (PE ratio) of -1.23.

      Ask ADVFN Intelligence (AI)

      INBX Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 31 2024
      INBX (-2.06%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      May 30 2024
      INBX (-2.06%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.786.2300319488812.5213.911.6811667212.99046961CS
      40.675.3048297703912.6314.3811.688067212.90784488CS
      12-1.67-11.155644622614.9716.8311.688502713.66493878CS
      26-2.87-17.748917748916.1717.7911.688582514.71303242CS
      52-22.16-62.492949802635.463610.825282427.88223687CS
      156-7.44-35.872709739620.7439.797.6741457624.86695919CS
      260-6.4-32.487309644719.750.977.6733291525.75277515CS

      INBX - Frequently Asked Questions (FAQ)

      What is the current Inhibrx Biosciences share price?
      The current share price of Inhibrx Biosciences is $ 13.30
      How many Inhibrx Biosciences shares are in issue?
      Inhibrx Biosciences has 14,475,904 shares in issue
      What is the market cap of Inhibrx Biosciences?
      The market capitalisation of Inhibrx Biosciences is USD 196.58M
      What is the 1 year trading range for Inhibrx Biosciences share price?
      Inhibrx Biosciences has traded in the range of $ 10.80 to $ 36.00 during the past year
      What is the PE ratio of Inhibrx Biosciences?
      The price to earnings ratio of Inhibrx Biosciences is -1.23
      What is the cash to sales ratio of Inhibrx Biosciences?
      The cash to sales ratio of Inhibrx Biosciences is 116.74
      What is the reporting currency for Inhibrx Biosciences?
      Inhibrx Biosciences reports financial results in USD
      What is the latest annual turnover for Inhibrx Biosciences?
      The latest annual turnover of Inhibrx Biosciences is USD 1.63M
      What is the latest annual profit for Inhibrx Biosciences?
      The latest annual profit of Inhibrx Biosciences is USD -154.96M
      What is the registered address of Inhibrx Biosciences?
      The registered address for Inhibrx Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Inhibrx Biosciences website address?
      The website address for Inhibrx Biosciences is www.inhibrx.com
      Which industry sector does Inhibrx Biosciences operate in?
      Inhibrx Biosciences operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MASS908 Devices Inc
      $ 3.665
      (85.10%)
      		74.76M
      FRGTFreight Technologies Inc
      $ 1.645
      (59.71%)
      		56.13M
      PTIXProtagenic Therapeutics Inc
      $ 0.3788
      (37.10%)
      		56.78M
      JFINJiayin Group Inc
      $ 9.3665
      (32.48%)
      		532.84k
      RAPPRapport Therapeutics Inc
      $ 9.20
      (28.67%)
      		271.68k
      TNYATenaya Therapeutics Inc
      $ 0.51005
      (-46.13%)
      		5.92M
      AGHAureus Greenway Holdings Inc
      $ 1.18
      (-45.62%)
      		922.57k
      STISolidion Technology Inc
      $ 0.179
      (-40.59%)
      		5.24M
      SAGSAG Holdings Ltd
      $ 0.5012
      (-32.40%)
      		343.51k
      JRVRJames River Group Holdings Ltd
      $ 3.33
      (-32.04%)
      		1M
      NVDANVIDIA Corporation
      $ 111.9003
      (-1.89%)
      		165.59M
      UOKAMDJM Ltd
      $ 0.1761
      (17.40%)
      		113.68M
      BTOGBit Origin Ltd
      $ 0.3874
      (21.33%)
      		105.35M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 10.96
      (-13.50%)
      		97.78M
      CYCUCycurion Inc
      $ 0.6913
      (15.01%)
      		81.18M

      INBX Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      INBX under $20
      👍️0
      Monksdream Monksdream 6 months ago
      INBX under $20
      👍️0
      Monksdream Monksdream 6 months ago
      INBX under $15
      👍️0
      Monksdream Monksdream 11 months ago
      INBX over $30
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      heres the dolla...boom!!
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      INBX DOLLA RUMMER IN PROCESS
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      INBX...PRE MARKET VOL
      👍️0
      Jaydixson1 Jaydixson1 2 years ago
      Seems to be dropping
      👍️0
      make it happen make it happen 2 years ago
      Numbers do not make sense. They need to raise so much to keep the Phases going. So much debt and money burn with worse quarters and barley any revs. Not bashing it's just what it is. 1,000's of percent's negative on profit. Revenue $0.18 Book Value -$0.12. Also imo this volume isn't sustainable 9 times normal as of now

      Profitability
      Profit Margin 0.00%
      Operating Margin -1,448.76%

      Management Effectiveness
      Return on Assets -37.98%
      Return on Equity -562.25%

      Income Statement
      Revenue 7.03M
      Revenue Per Share 0.18
      Quarterly Revenue Growth (yoy) -25.50%
      Gross Profit -64.21M
      EBITDA -100.6M
      Net Income Avi to Common -110.75M
      Diluted EPS -2.44

      Balance Sheet
      Total Debt 175.7M
      Book Value Per Share -0.13

      Cash Flow Statement
      Operating Cash Flow -90.16M
      Levered Free Cash Flow -46.31M
      👍️0

      Your Recent History

      NASDAQ
      INBX
      Inhibrx Biosciences
      BIT
      UC0ZZX
      Unicredit Bank
      BIT
      UC5QY5
      Unicredit Bank
      BIT
      S28784
      Societe Generale Effekten
      BIT
      UC3S87
      Unicredit Bank
      BIT
      VFEA
      Vanguard FTSE Emerging M...
      CSE
      SPLY
      Safe Supply Streaming
      AQSE
      ASIL.GB
      Amundi MSCI China ESG Le...
      BIT
      JEDI
      VanEck Space Innovators ...
      AQSE
      WTG
      Watchstone
      BIT
      UNI
      Unipol Assicurazioni
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads